Skip to main content
Clinical Trials/IRCT2016041927494N1
IRCT2016041927494N1
Completed
Phase 2

Review and Comparison of sedative effect in using of chloral hydrate and midazolam on children under voiding cystourethrogram

Vice chancellor for research, Arak University of Medical Sciences0 sites150 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Vesico uretro reflux.
Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Enrollment
150
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Arak University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Entrance general conditions to Study: children from 2 \- 12 years old both male \& female? Children with indication VCUG? children with ASA 1 or 2? obtaining the informed consent from parents or guardian of children To participate in the study
  • Exclusion general conditions from Study: History of systemic chronic diseases such as Renal failure, Respiratory disease and etc? history of narcotic abuse? history sensitivity to midazolam or chloral hydrate? history chronic psychiatric disease including: ADHA, Anxiety, Depression, psychos and Metal retardation.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials